Nasus Pharma (NSRX) P/E (2025 - 2026)
Nasus Pharma (NSRX) P/E from Aug 13, 2025 to Jul 20, 2026. The TTM Nasus Pharma (NSRX) P/E is -4.63. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Nasus Pharma (NSRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -4.63 | -67.10% |
| 2025 | -14.08 | N/A |
Comparison Nasus Pharma (NSRX) P/E with competitors
Nasus Pharma (NSRX) P/E is -4.63.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -318.31% |
| PFE | Pfizer Inc | 11.65 | -351.67% |
| NVO | Novo Nordisk | 11.79 | -354.63% |
| GSK | GSK Plc | 12.10 | -361.38% |
| SNY | Sanofi | 12.12 | -361.82% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -398.43% |
| OGN | Organon & Company | 14.33 | -409.39% |
| BIIB | Biogen Inc | 17.41 | -475.87% |
| GILD | Gilead Sciences Inc | 17.75 | -483.20% |
| NVS | Novartis AG | 21.60 | -566.38% |
| JNJ | Johnson & Johnson | 22.09 | -576.99% |
| AMGN | AMGEN Inc | 24.75 | -634.50% |
| MRK | Merck & Co Inc | 26.93 | -681.49% |
| AZN | Astrazeneca plc | 28.44 | -714.22% |
| LLY | Lilly(Eli) & Company | 48.44 | -1146.13% |
| ABBV | Abbvie Inc | 139.08 | -3103.45% |